Articles > Business magazines > International magazines > Nordic Business Report articles > October 2009

Article: Swedish Diamyd Medical to get SEK11 compensation from Apoteket.

Article from:
Nordic Business Report
Article date:
October 14, 2009
Copyright

NORDIC BUSINESS REPORT-14 October 2009-Swedish Diamyd Medical to get SEK11 compensation from Apoteket(C)1994-2009 M2 COMMUNICATIONS http://www.m2.com

14 October 2009 - Swedish biotech company Diamyd Medical AB (STO: DIAM B) said today it will receive SEK11m following a settlement agreement with local state-owned pharmacy group Apoteket AB regarding an invalidated clinical study.

In 2004, Diamyd Medical selected Apoteket to handle blinding, randomisation and labelling of a study with 160 latent autoimmune diabetes in adult (LADA) patients. The study was invalidated in 2007 as contradictory data from it gave ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Swedish Diamyd Medical may seek European ...
Nordic Business Report;  September 3, 2009 ;     574 words ... ... REPORT-3 September 2009-Swedish Diamyd Medical may seek European approval ... Swedish R&D company Diamyd Medical AB (STO: DIAM B) may apply ... in the USA, Lindner said. Diamyd Medical plans to seek marketing approval ...

Article: Borsveckan repeats "buy" on Swedish Diamyd ...
Nordic Business Report;  October 5, 2009 ;     517 words ... ... Borsveckan repeats "buy" on Swedish Diamyd Medical(C)1994-2009 M2 COMMUNICATIONS ... Swedish R&D company Diamyd Medical AB (STO: DIAM B) was especially ... issue. In mid-September, Diamyd Medical said it will implement a rights ...

Article: Swedish Diamyd Medical eyes to raise ...
Nordic Business Report;  October 14, 2009 ;     497 words ...NORDIC BUSINESS REPORT-14 October 2009-Swedish Diamyd Medical eyes to raise SEK219.2m(C)1994-2009 M2 ... com 14 October 2009 - Swedish R&D company Diamyd Medical AB (STO: DIAM B) said today it targets to raise ...

Article: Swedish Diamyd Medical eyes SEK220m in ...
Nordic Business Report;  September 15, 2009 ;     541 words ...NORDIC BUSINESS REPORT-15 September 2009-Swedish Diamyd Medical eyes SEK220m in rights issue(C)1994-2009 ... 15 September 2009 - Swedish R&D company Diamyd Medical AB (STO: DIAM B) said today it will carry out ...

Article: Swedish Diamyd Medical to get EUR 1.1m ...
ADP News Nordic;  October 14, 2009 ;     572 words ... ... 14, 2009 - Swedish biotech company Diamyd Medical AB (STO:DIAM B) said today it will ... invalidated clinical study. In 2004, Diamyd Medical selected Apoteket to handle blinding ... Apoteket's routines and documentation. Diamyd Medical aims to confirm earlier reported positive ...

Article: Swedish Diamyd Medical to include small ...
ADP News Nordic;  December 14, 2009 ;     700+ words ... ... 14, 2009 - Swedish biotech company Diamyd Medical AB (STO:DIAM B) said today that ... vaccine's safety profile is strong," Diamyd Medical's CEO Elisabeth Lindner said. The ... the USA and Canada. The purpose of Diamyd Medical's double-blind randomised, placebo ...

Article: Swedish Diamyd Medical close to completing ...
ADP News Nordic;  October 7, 2009 ;     700+ words ...(ADPnews) - Oct 7, 2009 - Swedish biotech company Diamyd Medical AB (STO:DIAM B) said today that it was close to completing the ... reduce the risk for acute and long-term diabetic complications, Diamyd Medical added.

Article: Swedish Diamyd Medical to launch EUR 21.5m ...
ADP News Nordic;  September 15, 2009 ;     529 words ...(ADPnews) - Sep 15, 2009 - Swedish R&D company Diamyd Medical AB (STO:DIAM B) unveiled today its decision to implement a preferential rights issue of SEK 220 million (USD 31.4m/EUR ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives